Pfizer Inc. (Pfizer) is a research-based, global biopharmaceutical company. The Company applies science and its global resources to improve health and well-being at every stage of life. Pfizer's diversified global health care portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and many consumer health care products. The Company operates in two business segments: Biopharmaceutical and Diversified. Biopharmaceutical includes the Primary Care, Specialty Care, Established Products, Emerging Markets and Oncology customer-focused units. Diversified includes Animal Health products that prevent and treat diseases in livestock and companion animals, and Consumer Healthcare products.

Pfizer develops and produces medicines and vaccines for a wide range of conditions including in the areas of immunology and inflammation, oncology, cardiovascular and metabolic diseases, neuroscience and pain. Pfizer's products include Lipitor (atorvastatin, used to lower LDL blood cholesterol); Lyrica (pregabalin, for neuropathic pain/fibromyalgia); Diflucan (fluconazole, an oral antifungal medication); Zithromax (azithromycin, an antibiotic); Viagra (sildenafil, for erectile dysfunction); and Celebrex/Celebra (celecoxib, an anti-inflammatory drug).

Company Growth (employees)
Type
Public
HQ
New York, US
Founded
1848
Size (employees)
96,500 (est)
Website
pfizer.com
Pfizer was founded in 1848 and is headquartered in New York, US

Key People at Pfizer

Ian C. Read

Ian C. Read

Chairman & CEO
Frank A. D'Amelio

Frank A. D'Amelio

EVP, CFO & Business Operations
Laurie J. Olson

Laurie J. Olson

EVP of Strategy, Portfolio and Commercial Operations
Chuck Hill

Chuck Hill

Executive Vice President, Worldwide Human Resources
Rady Johnson

Rady Johnson

Executive VP, Chief Compliance And Risk Officer
Mikael Dolsten

Mikael Dolsten

President, Worldwide Research & Development
Doug Lankler

Doug Lankler

Executive VP, General Counsel
Freda C. Lewis-Hall

Freda C. Lewis-Hall

EVP & Chief Medical Officer

Pfizer Office Locations

Pfizer has offices in New York, Buenos Aires, Bentley, Shanghai and in 39 other locations
New York, US (HQ)
235 East 42nd Street

Pfizer Data and Metrics

Pfizer Financial Metrics

Pfizer's revenue was reported to be $52.8 b in FY, 2016 which is a 8% increase from the previous period.
Numbers are in $, USD

Revenue (FY, 2016)

52.8 b

Revenue growth (FY, 2015 - FY, 2016), %

8%

Gross profit (FY, 2016)

40.5 b

Gross profit margin (FY, 2016), %

77%

Net income (FY, 2016)

7.2 b

EBIT (FY, 2016)

7.2 b

Market capitalization (26-May-2017)

191.8 b

Closing share price (26-May-2017)

32.2
Pfizer's current market capitalization is $191.8 b.
Numbers are in $, USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

51.6 b49.6 b48.9 b52.8 b

Revenue growth, %

(4%)(2%)8%

Cost of goods sold

9.6 b9.6 b9.6 b12.3 b

Gross profit

42 b40 b39.2 b40.5 b

Gross profit Margin, %

81%81%80%77%

Sales and marketing expense

14.4 b14.1 b14.8 b14.8 b

R&D expense

6.7 b8.4 b7.7 b7.9 b

Operating expense total

21 b22.5 b22.5 b22.7 b

EBIT

11.4 b9.1 b7 b7.2 b

EBIT margin, %

22%18%14%14%

Pre tax profit

15.7 b12.2 b9 b8.4 b

Income tax expense

4.3 b3.1 b2 b1.1 b

Net Income

22.1 b9.2 b7 b7.2 b
Numbers are in $, USDY, 2011Y, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Cash

3.2 b10.1 b2.2 b3.3 b3.6 b

Inventories

6.2 b5.7 b

Current Assets

56.2 b57.7 b43.8 b38.9 b

PP&E

12.4 b11.8 b

Goodwill

42.5 b42.1 b48.2 b54.4 b

Total Assets

172.1 b169.3 b167.5 b171.6 b

Accounts Payable

3.2 b3.4 b3.6 b4.5 b

Dividends Payable

1.7 b1.7 b1.9 b1.9 b

Total Debt

30.5 b31.5 b28.8 b

Current Liabilities

23.4 b21.6 b29.4 b31.1 b

Common Stock

461 m

Preferred Stock

24 m

Additional Paid-in Capital

77.3 b79 b81 b82.7 b

Retained Earnings

69.7 b72.2 b72 b71.8 b

Total Equity

76.6 b71.6 b

Debt to Equity Ratio

0.4 x0.4 x

Debt to Assets Ratio

0.2 x0.2 x0.2 x

Financial Leverage

2.2 x2.4 x
Numbers are in $, USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

22.1 b9.2 b

Accounts Receivable

940 m148 m21 m(134 m)

Inventories

(538 m)175 m(199 m)365 m

Accounts Payable

382 m297 m254 m871 m

Cash From Operating Activities

17.8 b16.9 b14.5 b15.9 b

Purchases of PP&E

(1.2 b)(1.2 b)(1.4 b)(1.8 b)

Cash From Investing Activities

(10.6 b)(5.7 b)(3 b)(7.8 b)

Short-term Borrowings

(1.2 b)(8.2 b)

Long-term Borrowings

(4.1 b)(2.1 b)(3 b)(7.7 b)

Dividends Paid

(6.6 b)(6.6 b)(6.9 b)(7.3 b)

Cash From Financing Activities

(15 b)(10 b)(10.2 b)(8.9 b)

Interest Paid

1.7 b1.6 b1.3 b1.5 b

Income Taxes Paid

2.9 b2.1 b2.4 b2.5 b
Numbers are in $, USDY, 2016

Revenue/Employee

543.5 k

Pfizer Operating Metrics

Y, 2014Y, 2015Y, 2016

Discovery Projects

91A90B96

Active Clinical Studies

448338

Phase III Trials

22A30B34

Drugs Approved by FDA

1

Pfizer Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
MedivationAugust 22, 2016$14 b
Anacor PharmaceuticalsJune 24, 2016$5.2 b
AllerganNovember 23, 2015$160 b

Pfizer Market Value History

Pfizer Revenue Breakdown

Pfizer Median Salaries

Source: 241 public H-1B filings from Pfizer

Pfizer Online and Social Media Presence

Pfizer News and Updates

Pfizer Company Life and Culture

You may also be interested in